Peptide Based Gastrointestinal Disorders Therapeutics Market Report By Segmentation, By Drug Type, By Distribution Channel with Forecast till 2022

Rockville, US, 2018-Apr-30 — /EPR Network/ — A freshly compiled business intelligent report, titled “Peptide Based Gastrointestinal Disorders Therapeutics Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been publicized to the vast archive of Fact.MR online repository. This 170-page study delivers all the vital details and information required to know about peptide based gastrointestinal disorders therapeutics market current as well as future prospects. The analysts of the study have gone through extensive research methodologies in order to generate data and information that reflects the latest market undercurrents and industry trends. For a deeper understanding of the market, a sub-category level analysis has been elaborated, by which readers and investors of the report will able to know that where the market stands to gain.

Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=190

Peptide is a biologically, naturally or artificially constituted form of amino acid monomers. Peptides can be utilized for treating various gastrointestinal disorders that mostly effect parts of the digestive system such as the gastrointestinal tract, large intestine, small intestine, stomach, esophagus, and rectum. Peptides are considered as an effective therapeutic agent for treating gastrointestinal diseases. Owing to their impressive preclinical results, an array of new peptide based gastrointestinal disorder therapeutics are expected to enter the market soon.

North America to Lead the Global Peptide Based Gastrointestinal Disorders Therapeutics Market

In terms of revenue, North America is expected to hold the dominant share of the global peptide based gastrointestinal disorders therapeutics market in 2017 and beyond. Factors such growing patient awareness and rapid adoption of peptide based therapeutics for treating various diseases are expected to support the growth of the market in the region.  During the forecast period, the market in the region is projected to surge at a robust CAGR of 13.9%.

On the basis of drugs, the linaclotide segment is expected to retain its dominant position over 2022. Currently, the segment accounts for more than two-third share of the market in terms of revenue. Towards the end of the forecast period, the linaclotide segment is estimated to reach a market valuation in excess of US$ 466 Mn.

Competition Tracking

Shire plc, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Allergan plc, Accredo Health Group, Inc., are the key market players profiled in the Fact.MR’s report. A majority of these companies are channelizing investment in further expansion of their product portfolio. This, in turn, is anticipated to result in introduction of more efficacious peptide based therapeutic drugs for curing gastrointestinal ailments.

Browse Full Report with TOC@ https://www.factmr.com/report/190/peptide-based-gastrointestinal-disorders-therapeutics-market

Table of Contents:

1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market – Executive Summary
2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Overview
   2.1. Introduction
   2.1.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Taxonomy
   2.1.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Definition
   2.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
   2.2.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Y-o-Y Growth
   2.3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
   2.4. Regulations
   2.5. Supply Chain
   2.6. Cost Structure
   2.7. Average Pricing Analysis
   2.8. Epidemiology
   2.9. Key Participants Market Presence (Intensity Map) By Region
3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Drug 
   3.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
   3.1.1. Teduglutide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
   3.1.1.1. Revenue (US$ Mn) Comparison, By Region
   3.1.1.2. Market Share Comparison, By Region
   3.1.1.3. Y-o-Y growth Comparison, By Region
   3.1.2. Linaclotide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022

Continued………….

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=190

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/